Endothelial activation by cytokines.
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. MANTOVANI@IRFMN.MNEGRI.IT
A
A
Mantovani
S
S
Sozzani
M
M
Introna
D000818:Animals; D001161:Arteriosclerosis / Q000503:physiopathology; D001327:Autoimmune Diseases / Q000503:physiopathology; D002318:Cardiovascular Diseases / Q000503:physiopathology; D003141:Communicable Diseases / Q000503:physiopathology; D016207:Cytokines / Q000494:pharmacology / Q000502:physiology*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology*; D016298:Hematopoietic Cell Growth Factors / Q000494:pharmacology / Q000502:physiology; D006801:Humans; D007372:Interferons / Q000494:pharmacology / Q000502:physiology; D007378:Interleukins / Q000494:pharmacology / Q000502:physiology; D009369:Neoplasms / Q000098:blood supply / Q000503:physiopathology; D014181:Transplantation Immunology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology / Q000502:physiology
D016207:Cytokines; D016298:Hematopoietic Cell Growth Factors; D007378:Interleukins; D014409:Tumor Necrosis Factor-alpha; D007372:Interferons